Alan Hoberman
Direktor/Vorstandsmitglied bei BIOXYTRAN, INC.
Vermögen: 136 272 $ am 30.04.2024
Aktive Positionen von Alan Hoberman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOXYTRAN, INC. | Direktor/Vorstandsmitglied | 02.11.2018 | - |
Independent Dir/Board Member | 02.11.2018 | - | |
Argus International, Inc.
Argus International, Inc. Industrial MachineryProducer Manufacturing Argus International, Inc. designs and manufactures machinery for the processing of printed circuit boards. Its products include LPI Spray Coating, Thin Film Coating, Hot Air Leveling, and Fusing. The company was founded on March 1, 1965 and is headquartered in Ringoes, NJ. | Vorstandsvorsitzender | - | - |
Präsident | - | - |
Karriereverlauf von Alan Hoberman
Ehemalige bekannte Positionen von Alan Hoberman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | Direktor/Vorstandsmitglied | - | 03.08.2018 |
Independent Dir/Board Member | - | 03.08.2018 | |
NANOMIX CORPORATION | Direktor/Vorstandsmitglied | 25.09.2014 | 15.09.2017 |
Independent Dir/Board Member | 25.09.2014 | 15.09.2017 | |
Argus Research Laboratories, Inc. | Corporate Officer/Principal | 01.01.1991 | 01.01.2013 |
BioXyTran, Inc. /Old/
BioXyTran, Inc. /Old/ Pharmaceuticals: MajorHealth Technology BioXyTran, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of treatments to prevent catastrophic brain damage resulting from hypoxic conditions following brain stroke. The company was founded in 2017 and is headquartered in Newton, MA. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Alan Hoberman
Pacific Western University | Doctorate Degree |
The University of Arkansas | Graduate Degree |
Drexel University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Operativ
Director/Board Member | 4 |
Independent Dir/Board Member | 3 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Producer Manufacturing | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOXYTRAN, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Boston Therapeutics, Inc.
Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
Argus International, Inc.
Argus International, Inc. Industrial MachineryProducer Manufacturing Argus International, Inc. designs and manufactures machinery for the processing of printed circuit boards. Its products include LPI Spray Coating, Thin Film Coating, Hot Air Leveling, and Fusing. The company was founded on March 1, 1965 and is headquartered in Ringoes, NJ. | Producer Manufacturing |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | Health Technology |
BioXyTran, Inc. /Old/
BioXyTran, Inc. /Old/ Pharmaceuticals: MajorHealth Technology BioXyTran, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of treatments to prevent catastrophic brain damage resulting from hypoxic conditions following brain stroke. The company was founded in 2017 and is headquartered in Newton, MA. | Health Technology |
Argus Research Laboratories, Inc. |
- Börse
- Insiders
- Alan Hoberman
- Erfahrung